Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Equity Analyst with 10+ years experience in fundamental and event-driven research.

On Smartkarma, I mainly publish insights on index flow events. This includes predicting regular and intra-review index changes and formulating market-neutral trading strategies based on flow catalysts. I also cover special situations such as mergers & acquisitions, equity offerings, buybacks, and other corporate restructuring events.

Index Rebal/Special Situations

Quiddity Leaderboard CSI Medical Dec26: 6 ADDs/DELs Expected; US$236mn One-Way Flows

Quiddity Leaderboard CSI 1000 Dec26: 200 Changes; US$1Bn+ One-Way

Quiddity Leaderboard F100/F250 Sep26: Three M&A Deals; Few F250 Changes + a Possible Transfer

Quiddity Leaderboard STAR 50/100 Jun26: Final Expectations; ~US$2.6bn Combined One-Way Flows

Quiddity Leaderboard Hang Seng Index Jun26: BeOne, Zijin, Cosco Shipping Among Our Top 10 Picks

Quiddity Leaderboard CSI Medical Jun26: Final Expectations

Quiddity Leaderboard CSI 300/​​500 Jun26: Final Expectations; ~US$10bn Collective One-Way Flows

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

Guangzhou Wondfo Biotech C-A / Index Rebalance

<ul>
<li>The June 2026 index review results for the CSI Medical Service Index were announced after market close on Friday 29th May 2026.</li>
<li>There will be 3 ADDs and 3 DELETEs for the CSI Medical Service index.</li>
<li>We expect one-way flows of approximately US$134mn in the June 2026 index rebal event.</li>
</ul>


The June 2026 index review results for the CSI Medical Service Index were announced after market close on Friday 29th May 2026.
There will be 3 ADDs and 3 DELETEs for the CSI Medical Service index.
We expect one-way flows of approximately US$134mn in the June 2026 index rebal event.


Shanghai MicroPort EP MedTech (688351 CH)

Guangdong Taienkang Pharmaceutical (301263 CH)

Quiddity CSI Medical Jun26 Results: 5/6 Correctly Predicted; US$134mn One-Way Flows